K191407: Novalung System (FDA 510(k) & Recall Dossier)

U.S. FDA 510(k) Premarket Notification K191407 (Novalung System, cleared 2020-02-21 for Fresenius Medical Care Renal Therapies Group, LLC) reconciled with CDRH recall records on Predicate Ledger.

Reconciled U.S. FDA 510(k) Premarket Notification Metadata for K191407
Regulatory FieldVerified FDA Record
FDA 510(k) NumberK191407
Cleared Device Trade / Generic NameNovalung System
FDA Applicant on FilingFresenius Medical Care Renal Therapies Group, LLC
FDA 3-Letter Product ClassificationProduct Code QJZ
FDA Substantial Equivalence Decision Date2020-02-21
De-Broadcasted Recall LinkageLinked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026)

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Fresenius / Fresenius Kabi across sibling Meru public-data platforms.

Inspect consolidated manufacturer lineage at Fresenius Medical Care Renal Therapies Group, LLC, compare peer devices under FDA Product Code QJZ, or browse all 20 FDA clinical specialties.

Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.